https://pharmadog.xyz/news/425235 pharmadog en 2026-09-19T10:00:19.000Z Novartis faces another setback while Novo drops Nordisk partnership https://pharmadog.xyz/news/423126 pharmadog en 2026-09-18T21:48:00.000Z GF Blends recalls AIP flour and flatbread mixes over undeclared wheat gluten https://pharmadog.xyz/news/422451 pharmadog en 2026-09-18T20:41:21.000Z All 50 states, DC, and Puerto Rico join new Medicaid most-favored-nation drug pricing model, Trump says https://pharmadog.xyz/news/422495 pharmadog en 2026-09-18T20:22:36.000Z Trump announces GENEROUS model, securing pharma deals to cut Medicaid drug prices https://pharmadog.xyz/news/422283 pharmadog en 2026-09-18T19:32:11.000Z FDA approves Eli Lilly's oral SERD Inluriyo combo for second-line metastatic breast cancer https://pharmadog.xyz/news/422139 pharmadog en 2026-09-18T18:36:37.000Z China unveils five-year plan to grow biotech sector from $3M to $522B by 2030 https://pharmadog.xyz/news/421839 pharmadog en 2026-09-18T17:08:19.000Z China biotech policy debate moves to Washington for live discussion https://pharmadog.xyz/news/421671 pharmadog en 2026-09-18T16:51:03.000Z EU regulator backs Novo's hemophilia A preventive therapy and recommends seven additional drugs https://pharmadog.xyz/news/421715 pharmadog en 2026-09-18T16:41:53.000Z HCA Healthcare sues Independence Blue Cross over $345,000 in unpaid Texas hospital claims https://pharmadog.xyz/news/421672 pharmadog en 2026-09-18T16:26:20.000Z FDA reports decline in initial drug rejections, refutes claims of rising denials https://pharmadog.xyz/news/421567 pharmadog en 2026-09-18T15:51:00.000Z Xenon shares tumble up to 30% after pausing depression trial over neuropsychiatric events https://pharmadog.xyz/news/421527 pharmadog en 2026-09-18T15:23:48.000Z Electra Therapeutics raises $350M in IPO to fund pivotal immune-disease antibody development https://pharmadog.xyz/news/421503 pharmadog en 2026-09-18T15:07:57.000Z China unveils new five-year plan to boost biotech and pharma and compete globally https://pharmadog.xyz/news/421335 pharmadog en 2026-09-18T14:46:20.000Z Anthropic opens limited access to Mythos AI for life-science researchers https://pharmadog.xyz/news/421399 pharmadog en 2026-09-18T14:43:50.000Z GSK adds two China cancer-therapy licensing deals, keeping pace with industry partnership surge https://pharmadog.xyz/news/421400 pharmadog en 2026-09-18T14:24:00.000Z Ultragenyx prices Sanfilippo gene therapy at $4 million as it gains a second FDA approval; Bristol Myers halts Orum cancer drug https://pharmadog.xyz/news/422258 pharmadog en 2026-09-18T14:24:00.000Z Artelo’s oral cannabinoid agonist matches semaglutide weight loss in obese mice, doubles effect when combined https://pharmadog.xyz/news/421083 pharmadog en 2026-09-18T13:59:04.000Z Xenon shares plunge 23% after voluntary hold on psychiatry trials, despite filing NDA for epilepsy drug https://pharmadog.xyz/news/421103 pharmadog en 2026-09-18T13:42:29.000Z Roche opens new research center in Boston, expanding its local presence https://pharmadog.xyz/news/421104 pharmadog en 2026-09-18T13:38:24.000Z IN8bio appoints Oxana Polyakova as senior vice president of R&D https://pharmadog.xyz/news/421105 pharmadog en 2026-09-18T13:29:38.000Z U.S. drafts new investment rules to keep pharma licensing deals with China viable https://pharmadog.xyz/news/420915 pharmadog en 2026-09-18T12:32:03.000Z Ultragenyx receives FDA approval for Fayuvi, first therapy for Sanfilippo syndrome type A, priced at $3.95 M https://pharmadog.xyz/news/420916 pharmadog en 2026-09-18T12:19:39.000Z BMS drops Orum’s targeted degrader after Phase 1 results https://pharmadog.xyz/news/420935 pharmadog en 2026-09-18T12:11:48.000Z Panel discusses how questions about health equity shape public trust in science https://pharmadog.xyz/news/421814 pharmadog en 2026-09-18T11:24:00.000Z Novo Nordisk acquires three early-stage obesity programs from Kallyope https://pharmadog.xyz/news/420723 pharmadog en 2026-09-18T11:00:21.000Z Legend Biotech appoints former Novartis exec Ingrid Zhang as CEO amid falling share price https://pharmadog.xyz/news/421202 pharmadog en 2026-09-18T09:47:00.000Z Biopharma prediction markets raise insider-info concerns, regulators weigh oversight https://pharmadog.xyz/news/421647 pharmadog en 2026-09-18T09:35:00.000Z Medtronic secures FDA clearance for LigaSure vessel sealer on Hugo robotic platform https://pharmadog.xyz/news/421479 pharmadog en 2026-09-18T08:59:00.000Z FDA clears Aptitude’s latest Metrix molecular dx to test for COVID https://pharmadog.xyz/news/420157 pharmadog en 2026-09-18T08:30:00.000Z Sudan civil war forces cancer patients to endure hazardous journeys for treatment https://pharmadog.xyz/news/420158 pharmadog en 2026-09-18T08:30:00.000Z Geriatrician urges careful use of AI predictions for older patients https://pharmadog.xyz/news/420155 pharmadog en 2026-09-18T08:30:00.000Z Doctors urged to tell patients Asian glow signals health risk, not harmless quirk https://pharmadog.xyz/news/420156 pharmadog en 2026-09-18T08:30:00.000Z Rise in Young Men Seeking Cosmetic Surgery Driven by Social Media Influence, Surgeon Observes https://pharmadog.xyz/news/420530 pharmadog en 2026-09-18T05:33:00.000Z Xenon pauses enrollment in phase 3 depression trials after reports of psychosis and other neuropsychiatric events https://pharmadog.xyz/news/421774 pharmadog en 2026-09-18T04:00:00.000Z FDA updates instructions for NOxBOXi nitric oxide delivery system after leak risk identified https://pharmadog.xyz/news/422218 pharmadog en 2026-09-18T04:00:00.000Z Spectra Medical recalls Sodium Chloride Flush ampules due to serious safety risk https://pharmadog.xyz/news/420086 pharmadog en 2026-09-18T03:42:00.000Z BMS abandons $100 million Orum degrader-antibody conjugate after early phase-1 results https://pharmadog.xyz/news/419918 pharmadog en 2026-09-18T03:01:00.000Z Electra Therapeutics raises $350 million in oversubscribed IPO https://pharmadog.xyz/news/418679 pharmadog en 2026-09-18T00:43:12.000Z Electra Therapeutics raises $350 million in Nasdaq IPO to fund commercial expansion https://pharmadog.xyz/news/418743 pharmadog en 2026-09-18T00:42:00.000Z Electra Therapeutics raises $350M in biotech IPO, fueling rare disease drug development https://pharmadog.xyz/news/422969 pharmadog en 2026-09-18T00:00:00.000Z FDA faces nominee hearing, hiring woes and reviews of psychedelics and testosterone therapies https://pharmadog.xyz/news/418171 pharmadog en 2026-09-17T22:09:30.000Z Health secretary Kennedy launches program to accelerate autism diagnosis https://pharmadog.xyz/news/421402 pharmadog en 2026-09-17T21:39:00.000Z Lisata acquires Marea Therapeutics, securing $225M financing to advance two mid-stage drugs https://pharmadog.xyz/news/417835 pharmadog en 2026-09-17T20:40:04.000Z Health Secretary RFK Jr. delivers anti‑vaccine keynote at Children’s Health Defense conference https://pharmadog.xyz/news/417623 pharmadog en 2026-09-17T19:19:36.000Z Bristol Myers ends $100M Phase 1 cancer ADC program https://pharmadog.xyz/news/417347 pharmadog en 2026-09-17T18:56:20.000Z CMS offers Medicare pricing program exemptions to drugmakers who add Medicaid rebates https://pharmadog.xyz/news/417348 pharmadog en 2026-09-17T18:27:10.000Z FDA confronts surge of Chinese biotech firms as they become key industry players https://pharmadog.xyz/news/417706 pharmadog en 2026-09-17T18:26:43.000Z FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A https://pharmadog.xyz/news/417223 pharmadog en 2026-09-17T18:00:00.000Z Rare genetic variant linked to much higher lung cancer risk in never-smokers https://pharmadog.xyz/news/417179 pharmadog en 2026-09-17T17:01:24.000Z UK parliamentary committees demand probe into cost of US-UK pharma trade deal https://pharmadog.xyz/news/417011 pharmadog en 2026-09-17T16:47:15.000Z Cellares signs first Asian manufacturing deal with Taiwan's GenomeFrontier Therapeutics for CAR-T production https://pharmadog.xyz/news/417055 pharmadog en 2026-09-17T16:26:18.000Z Definium shares new psychedelics data and court reprieve for international researchers discussed on The Readout LOUD https://pharmadog.xyz/news/417075 pharmadog en 2026-09-17T15:55:00.000Z Novo and Orbis strike up to $1.4 billion partnership to develop oral peptide macrocycles for cardiometabolic disease https://pharmadog.xyz/news/416844 pharmadog en 2026-09-17T15:28:07.000Z Michael J. Fox Foundation backs Ariadne Bio's non-hallucinogenic psychedelic for Parkinson's https://pharmadog.xyz/news/416867 pharmadog en 2026-09-17T15:21:34.000Z Novo Nordisk signs up to $1.4 billion deal with Orbis Medicines to develop oral macrocycle cardiometabolic drugs https://pharmadog.xyz/news/420866 pharmadog en 2026-09-17T15:18:00.000Z Chutes & Ladders—Legend poaches Novartis vet to boost commercial potential https://pharmadog.xyz/news/416845 pharmadog en 2026-09-17T15:17:40.000Z CMS launches 10-year ACCESS health-tech pilot for Medicare https://pharmadog.xyz/news/416907 pharmadog en 2026-09-17T15:09:00.000Z North Immunology to go public via reverse merger with Aethlon, targeting eczema market https://pharmadog.xyz/news/416611 pharmadog en 2026-09-17T14:57:41.000Z Kennedy appoints eight specialists to U.S. Preventive Services Task Force, ending year-long vacancy https://pharmadog.xyz/news/416567 pharmadog en 2026-09-17T14:52:34.000Z Endpoints 11 reveals 2026’s most promising biotech startups at Boston gala https://pharmadog.xyz/news/416568 pharmadog en 2026-09-17T14:34:00.000Z Roche's Lunsumio clears Phase 3 hurdle, paving way for broader label in indolent lymphoma https://pharmadog.xyz/news/416612 pharmadog en 2026-09-17T14:30:37.000Z Startup launches trial of psychedelic-style drug for Parkinson’s symptom https://pharmadog.xyz/news/416613 pharmadog en 2026-09-17T14:17:03.000Z FDA staffing shortage limits ability to hire new employees, raising concerns for health-care oversight https://pharmadog.xyz/news/416614 pharmadog en 2026-09-17T14:11:18.000Z Study finds purer fentanyl will not curb U.S. overdose deaths https://pharmadog.xyz/news/416591 pharmadog en 2026-09-17T14:01:44.000Z Webinar Explores Manufacturing Risks and Partner Strategies for the Next Five Years https://pharmadog.xyz/news/416443 pharmadog en 2026-09-17T13:42:03.000Z Biotech sector expected to weather Fed rate hike despite higher capital costs https://pharmadog.xyz/news/416444 pharmadog en 2026-09-17T13:39:53.000Z Novartis' $12B Avidity deal falters as DM1 therapy misses Phase 3 endpoint https://pharmadog.xyz/news/416419 pharmadog en 2026-09-17T13:11:09.000Z General Catalyst outlines tech collaborations with Summa Health after hospital acquisition https://pharmadog.xyz/news/416615 pharmadog en 2026-09-17T13:09:13.000Z Zocdoc adds chatbot scheduling and updates on Medicare ACCESS